Regeneron Pharmaceuticals Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Millions BRL. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	411,598	436,198	474,006	453,222	407,367	367,893
Market Cap Growth	0.62%	-7.98%	4.59%	11.26%	10.73%	38.93%
Enterprise Value	330,048	347,938	377,624	390,193	352,972	319,306
Last Close Price	67.12	70.85	72.51	67.79	62.71	59.09
PE Ratio	16.59	17.58	17.37	23.63	17.76	8.18
PS Ratio	5.21	5.52	5.40	7.12	6.33	4.11
PB Ratio	2.39	2.53	2.61	3.60	3.40	3.52
P/TBV Ratio	2.49	2.64	2.72	3.75	3.54	3.52
P/FCF Ratio	18.31	19.41	20.91	24.10	17.42	10.11
P/OCF Ratio	15.01	15.91	17.34	20.33	15.37	9.32
EV/Sales Ratio	4.48	4.40	4.30	6.13	5.49	3.57
EV/EBITDA Ratio	15.02	14.88	13.19	17.28	12.51	6.18
EV/EBIT Ratio	17.37	17.06	14.73	19.00	13.37	6.37
EV/FCF Ratio	14.68	15.48	16.66	20.75	15.09	8.78
Debt / Equity Ratio	0.10	0.10	0.10	0.11	0.12	0.14
Debt / EBITDA Ratio	0.69	0.69	0.63	0.60	0.52	0.29
Debt / FCF Ratio	0.73	0.73	0.80	0.72	0.63	0.41
Net Debt / Equity Ratio	-0.51	-0.51	-0.51	-0.52	-0.51	-0.52
Net Debt / EBITDA Ratio	-3.74	-3.74	-3.23	-2.89	-2.17	-1.06
Net Debt / FCF Ratio	-3.89	-3.89	-4.09	-3.47	-2.61	-1.51
Asset Turnover	0.37	0.37	0.40	0.42	0.45	0.76
Inventory Turnover	2.53	2.53	2.51	2.51	2.37	2.74
Quick Ratio	3.28	3.28	3.86	4.82	4.16	2.98
Current Ratio	4.13	4.13	4.73	5.69	5.06	3.56
Return on Equity (ROE)	14.87%	14.87%	15.95%	16.26%	20.94%	54.21%
Return on Assets (ROA)	5.91%	5.91%	7.31%	8.49%	11.42%	26.39%
Return on Invested Capital (ROIC)	12.54%	13.04%	18.58%	22.38%	26.65%	60.13%
Return on Capital Employed (ROCE)	10.20%	10.20%	12.30%	14.30%	19.20%	41.80%
Earnings Yield	6.03%	5.69%	5.76%	4.23%	5.63%	12.23%
FCF Yield	5.46%	5.15%	4.78%	4.15%	5.74%	9.89%
Dividend Yield	0.33%	27.37%	-	-	-	-
Payout Ratio	8.22%	8.22%	-	-	-	-
Buyback Yield / Dilution	5.65%	5.65%	-1.23%	-0.18%	-1.16%	2.52%
Total Shareholder Return	5.98%	33.01%	-1.23%	-0.18%	-1.16%	2.52%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.